NEW YORK, Oct. 17, 2013 /PRNewswire-iReach/ -- Reproductive Medicine Associates of New York (RMA of NY) will be presenting data regarding alcohol intake and infertility at the 69th Annual Meeting of the American Society for Reproductive Medicine in Boston, Massachusetts.
Dara Godfrey M.S., R.D. presents original research entitled,Assisted Reproductive Registered Dietitian Assessment: Does Prior Alcohol Intake Affect A Women's Cycle Outcome? on Thursday, October 17th as part of the ASRM Nutrition session.
Dara Godfrey is a registered dietitian with RMA of New York who specializes in assisting patients to achieve healthy lifestyles. While researchers have documented the dangerous effects of alcohol intake on the fetus during gestation, there was considerable debate about whether pre-conceptual alcohol consumption had any negative effects. The study examined whether alcohol consumption in women, prior to nutritional consultation with a registered dietitian, is associated with variation in assisted reproduction technology outcomes. The authors observed alcohol consumption in 42.7% of patients presented for infertility treatment, of which 75.6% consumed more than 2 drinks per week, 14.6% consumed 3-5 drinks per week and 9.8% consumed more than 6 drinks per week. Interestingly, a significantly higher positive pregnancy rate (PR) (70.7%) was observed in ART patients who self-reported alcohol consumption.
Godfrey states, "Our practice advises patients to limit their alcohol consumption, but reassures patients that prior alcohol consumption will not impede their future reproductive potential."
Dara Godfrey obtained a Bachelor of Science in Food & Nutrition from The University of Western Ontario and later received both her RD and a Masters in Nutrition from New York University. She has also worked extensively with Mount Sinai Medical Center in Manhattan.
About Reproductive Medicine Associates of New York
Reproductive Medicine Associates of New York (RMA of New York) is widely recognized as a national and international leader in state-of-the-art reproductive medicine. Led by an integrated team of doctors and scientists with extensive reproductive endocrinology, fertility and urology experience and training, RMA of New York consistently reports IVF success rates to the Society for Assisted Reproductive Technology (SART) and the Center for Disease Control and Prevention (CDC) and is internationally recognized for achieving high success rates in the treatment of infertility. RMA of New York maximizes access to care by helping patients explore all insurance coverage and financing options available for treatment. RMA of New York is sensitive to the needs of the LGBT community, women choosing single or same-sex motherhood, as well as women interested in elective fertility preservation. Headquartered in midtown Manhattan, RMA of New York has patient care facilities in Garden City, White Plains, Brooklyn and Cornwall, NY. For more information, please visit www.rmany.com.
Media Contact: Victoria Andretta, Reproductive Medicine Associates of New York, 212-756-5777, firstname.lastname@example.org
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Reproductive Medicine Associates of New York